However, depletion of CD25+ Tregs in metastatic melanoma (MM) patients treated with IL-2 resulted in the rapid reaccumulation of suppressive CD25+FOXP3+ Tregs in the periphery (Powell Jr et al, 2007a). The gene discussed is FOXP3; the disease is Miyoshi myopathy.